BRIDGE PHARMA

Serial Number 97978608
606

Registration Progress

Application Filed
Jan 18, 2023
Under Examination
Nov 5, 2024
Approved for Publication
Sep 10, 2024
Published for Opposition
Sep 10, 2024
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Feb 08, 2026 34 days
Revival assistance for abandoned trademark

Trademark Image

BRIDGE PHARMA

Basic Information

Serial Number
97978608
Filing Date
January 18, 2023
Published for Opposition
September 10, 2024
Abandonment Date
December 8, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 8, 2025
Classes
005 040

Rights Holder

Bridgewest International Holdings LLC

16
Address
701 Brickell Avenue, Suite 1490
Miami, FL 33131

Ownership History

Bridgewest International Holdings LLC

Original Applicant
16
Miami, FL

Bridgewest International Holdings LLC

Owner at Publication
16
Miami, FL

Legal Representation

Attorney
Lisel M. Ferguson

USPTO Deadlines

Next Deadline
34 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
February 08, 2026

Application History

37 events
Date Code Type Description Documents
Dec 8, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 8, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 8, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 8, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 9, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 8, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 25, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 25, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 25, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 25, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 25, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 31, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 31, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 31, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 5, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 10, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 7, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 7, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
May 14, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Aug 6, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 7, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jun 7, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
May 14, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Mar 7, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 7, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Mar 7, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Jan 25, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 24, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 25, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 25, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 25, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 16, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 25, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 21, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for use by humans, namely, sterile injectable pharmaceutical preparations for the treatment of dehydration, low potassium levels, bleeding, infection, and pain
Class 040
Custom manufacture of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain

Classification

International Classes
005 040

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"